IGF1 and invasive breast carcinoma: The results did not differ appreciably when we analyzed postmenopausal women, whereas in premenopausal women, only monocyte count, Gamma glutamyl transferase, IGF-1, SHBG, and testosterone were associated with invasive breast cancer risk (Ptrend <0.05) (Supplementary Table 7).